Arrowhead Pharmaceuticals (ARWR) EBITDA Margin Growth (5y) (2015 - 2026)
Arrowhead Pharmaceuticals (ARWR) EBITDA Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Arrowhead Pharmaceuticals | 12.23 Bn | 10.63 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15,659.00 |
| Mar 31, 2026 | -10,553.00 |
| Dec 31, 2025 | 12,837.00 |
| Sep 30, 2025 | 67,382.00 |
| Jun 30, 2025 | -53,796.00 |
| Mar 31, 2025 | 16,476.00 |
| Dec 31, 2024 | -644,000.00 |
| Dec 31, 2023 | -387,684.00 |
| Sep 30, 2023 | -57,375.00 |
| Jun 30, 2023 | 153,966.00 |
| Mar 31, 2023 | 234,542.00 |
| Dec 31, 2022 | 32,620.00 |
| Sep 30, 2022 | -14,786.00 |
| Jun 30, 2022 | -16,378.00 |
| Mar 31, 2022 | 9,559.00 |
| Dec 31, 2021 | 11,059.00 |
| Sep 30, 2021 | 6.96 Mn |
| Jun 30, 2021 | 4.88 Mn |
| Mar 31, 2021 | 4.85 Mn |
| Dec 31, 2020 | 4.41 Mn |